The Prognostic Value of the CD8+PD-1+/CD4+PD-1+ (PERLS) Ratio for Leukemic Transformation in MDS.

Hematol Rep · 2026 · PMC13116684 · PMID 42042194

Europe PMC DOI

hedged sentence

0.6900

closest p · 13.8× alpha

0.6900

boldest claim

The sentences

did not reach statistical significancep ≈ 0.69not close (p > 0.1)

1.05), although these differences did not reach statistical significance (Mann–Whitney U test, p ≈ 0.69 and p ≈ 0.58, respectively).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

The Prognostic Value of the CD8&lt;sup&gt;+&lt;/sup&gt;PD-1&lt;sup&gt;+&lt;/sup&gt;/CD4&lt;sup&gt;+&lt;/sup&gt;PD-1&lt;sup&gt;+&lt;/sup&gt; (PERLS) Ratio for Leukemic Transformation in MDS.

The sentences

The Prognostic Value of the CD8<sup>+</sup>PD-1<sup>+</sup>/CD4<sup>+</sup>PD-1<sup>+</sup> (PERLS) Ratio for Leukemic Transformation in MDS.